Pierre Gaudreault is President of Asia (Emerging Markets) for Pfizer Biopharmaceuticals Group. He is a well-respected corporate executive and thought leader in the pharmaceutical industry, and a highly experienced professional with more than 30 years of industry experiences in Canada, Europe, China, Japan and the Asia Pacific region. Pierre also sits on the Board of Directors of the US-ASEAN Business Council.
Pierre spent majority of his career at Pfizer where he acquired extensive expertise in corporate management and go-to-market models, as well as developed in-depth knowledge about multiple health care systems and archetypes across the globe.
In line with Pfizer’s purpose: breakthroughs that change patients’ lives, Pierre is leading the innovative agenda of Pfizer in Asia through its six franchises including Vaccines, Oncology, Rare Disease, Inflammation & Immunology, Internal Medicines and Hospital, whereby each one is uniquely positioned to benefit patients and change their lives.
Pierre holds a Science degree in Molecular Biology from Laval University in Canada. He is married and has four daughters.